(Q35082012)

6 August 2017

1 reference

title

Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations (English)

1 reference

6 August 2017

John D Reveille

1

1 reference

6 August 2017

1 April 2003

1 reference

Current Rheumatology Reports

6 August 2017

1 reference

6 August 2017

5

1 reference

6 August 2017

160-167

1 reference

6 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-003-0045-1

6 August 2017

0 references

cites work

Epidemiology of fatal systemic sclerosis (diffuse scleroderma). A 15-year survey in Baltimore

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-003-0045-1

Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-003-0045-1

An epidemiological study of scleroderma in the West Midlands

21 January 2018

1 reference

12 December 2020

Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies

1 reference

12 December 2020

Progressive systemic sclerosis in south India

1 reference

12 December 2020

Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979

1 reference

12 December 2020

Association of the TNFa13 microsatellite with systemic sclerosis in Japanese patients

1 reference

12 December 2020

Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis

1 reference

12 December 2020

Geographical clustering of mortality from systemic sclerosis in the Southeastern United States, 1981-90.

1 reference

12 December 2020

Anti-fibrillarin antibodies in systemic sclerosis

1 reference

12 December 2020

Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire

1 reference

12 December 2020

A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis

1 reference

12 December 2020

Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.

1 reference

12 December 2020

Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.

1 reference

12 December 2020

Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis.

1 reference

12 December 2020

Diffuse systemic sclerosis and related diseases in Thailand

1 reference

12 December 2020

Systemic sclerosis prevalence and mortality in Sydney 1974-88

1 reference

12 December 2020

Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies

1 reference

12 December 2020

Association of HLA-DR5 (DR11) with systemic sclerosis (scleroderma) in Mexican patients

1 reference

12 December 2020

Racial differences in scleroderma among women in Michigan

1 reference

12 December 2020

Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis

1 reference

12 December 2020

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

12 December 2020

Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations.

1 reference

12 December 2020

Association of HLA class II genes with systemic sclerosis in Koreans

1 reference

12 December 2020

A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation

1 reference

12 December 2020

Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population

1 reference

12 December 2020

Molecular genetics of systemic sclerosis.

1 reference

12 December 2020

Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus

1 reference

12 December 2020

Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis

1 reference

12 December 2020

Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features.

1 reference

12 December 2020

African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease

1 reference

12 December 2020

Racial differences in the frequencies of scleroderma-related autoantibodies

1 reference

12 December 2020

Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles

1 reference

12 December 2020

Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans

1 reference

12 December 2020

Serological profiles in the connective tissue diseases in Zimbabwean patients

1 reference

12 December 2020

Association of TAP1 and TAP2 with systemic sclerosis in Japanese

1 reference

12 December 2020

HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis).

1 reference

12 December 2020

Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants

1 reference

12 December 2020

Categorization of humans in biomedical research: genes, race and disease

1 reference

12 December 2020

HLA-DRB1 and DQB1 genes in Japanese patients with systemic sclerosis.

1 reference

12 December 2020

Y chromosome sequence variation and the history of human populations

1 reference

12 December 2020

The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans

1 reference

12 December 2020

The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma)

1 reference

12 December 2020

Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma

1 reference

12 December 2020

Severe restrictive lung disease in systemic sclerosis.

1 reference

12 December 2020

Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype

1 reference

12 December 2020

Antinuclear antibodies in systemic sclerosis. Clinical and ethnic associations

1 reference

12 December 2020

Scleroderma in South Australia: epidemiological observations of possible pathogenic significance

1 reference

12 December 2020

Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody

1 reference

12 December 2020

Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.

1 reference

12 December 2020

Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma)

1 reference

12 December 2020

Epidemiological study of patients with systemic sclerosis in Tokyo

1 reference

12 December 2020

TNF-alpha and TNF-beta gene polymorphisms in systemic sclerosis

1 reference

12 December 2020

HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies

1 reference

12 December 2020

Systemic sclerosis in Iceland. A nationwide epidemiological study

1 reference

12 December 2020

Limitations in the use of race in the study of disease causation

1 reference

12 December 2020

10.1007/S11926-003-0045-1

Identifiers

DOI

1 reference

release_2yrsacfcdfcy7hpmlvzz5ociti

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2yrsacfcdfcy7hpmlvzz5ociti

24 November 2022

mapped directly with Wikidata item

PubMed ID

12628048

1 reference

PubMed ID

12628048